| A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria JA Stoute, M Slaoui, DG Heppner, P Momin, KE Kester, P Desmons, ... New England Journal of Medicine 336 (2), 86-91, 1997 | 1087 | 1997 |
| Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans SJ McConkey, WHH Reece, VS Moorthy, D Webster, S Dunachie, ... Nature medicine 9 (6), 729-735, 2003 | 711 | 2003 |
| Efficacy of RTS, S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial KA Bojang, PJM Milligan, M Pinder, L Vigneron, A Alloueche, KE Kester, ... The Lancet 358 (9297), 1927-1934, 2001 | 682 | 2001 |
| Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS, S/AS01B and RTS, S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of … KE Kester, JF Cummings, O Ofori-Anyinam, CF Ockenhouse, U Krzych, ... Journal of Infectious Diseases 200 (3), 337-346, 2009 | 582* | 2009 |
| The promise of mRNA vaccines: a biotech and industrial perspective NAC Jackson, KE Kester, D Casimiro, S Gurunathan, F DeRosa npj Vaccines 5 (1), 11, 2020 | 386 | 2020 |
| Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against Experimental Plasmodium falciparum Malaria KE Kester, DA McKinney, N Tornieporth, CF Ockenhouse, DG Heppner, ... The Journal of infectious diseases 183 (4), 640-647, 2001 | 374 | 2001 |
| A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection … WHH Reece, M Pinder, PK Gothard, P Milligan, K Bojang, T Doherty, ... Nature medicine 10 (4), 406-410, 2004 | 342 | 2004 |
| Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria CF Ockenhouse, P Sun, DE Lanar, BT Wellde, BT Hall, K Kester, ... Journal of Infectious Diseases 177 (6), 1664-1673, 1998 | 339 | 1998 |
| Long-term efficacy and immune responses following immunization with the RTS, S malaria vaccine JA Stoute, KE Kester, U Krzych, BT Wellde, T Hall, K White, G Glenn, ... The Journal of infectious diseases 178 (4), 1139-1144, 1998 | 326 | 1998 |
| Protective immunity induced with malaria vaccine, RTS, S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-γ P Sun, R Schwenk, K White, JA Stoute, J Cohen, WR Ballou, G Voss, ... The Journal of Immunology 171 (12), 6961-6967, 2003 | 294 | 2003 |
| Towards an RTS, S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research DG Heppner Jr, KE Kester, CF Ockenhouse, N Tornieporth, O Ofori, ... Vaccine 23 (17-18), 2243-2250, 2005 | 256 | 2005 |
| Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A MD Spring, JF Cummings, CF Ockenhouse, S Dutta, R Reidler, E Angov, ... PloS one 4 (4), e5254, 2009 | 236 | 2009 |
| Potent induction of focused Th1-type cellular and humoral immune responses by RTS, S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine A Lalvani, P Moris, G Voss, AA Pathan, KE Kester, R Brookes, E Lee, ... The Journal of infectious diseases 180 (5), 1656-1664, 1999 | 215 | 1999 |
| Update on the clinical development of candidate malaria vaccines WR Ballou, M Arevalo-Herrera, D Carucci, TL Richie, G Corradin, C Diggs, ... The Intolerable Burden of Malaria II: What's New, What's Needed: Supplement …, 2004 | 202 | 2004 |
| The relationship between RTS, S vaccine-induced antibodies, CD4+ T cell responses and protection against Plasmodium falciparum infection MT White, P Bejon, A Olotu, JT Griffin, EM Riley, KE Kester, ... PloS one 8 (4), e61395, 2013 | 201 | 2013 |
| Guidelines for the prevention of infections associated with combat-related injuries: 2011 update: endorsed by the Infectious Diseases Society of America and the Surgical … DR Hospenthal, CK Murray, RC Andersen, RB Bell, JH Calhoun, ... Journal of Trauma and Acute Care Surgery 71 (2), S210-S234, 2011 | 181 | 2011 |
| Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria CF Ockenhouse, W Hu, KE Kester, JF Cummings, A Stewart, DG Heppner, ... Infection and immunity 74 (10), 5561-5573, 2006 | 170 | 2006 |
| Evaluation of RTS, S/AS02A and RTS, S/AS01B in adults in a high malaria transmission area ME Polhemus, SA Remich, BR Ogutu, JN Waitumbi, L Otieno, S Apollo, ... PloS one 4 (7), e6465, 2009 | 148 | 2009 |
| Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS, S/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research KE Kester, JF Cummings, CF Ockenhouse, R Nielsen, BT Hall, ... Vaccine 26 (18), 2191-2202, 2008 | 143 | 2008 |
| Opportunistic pulmonary infections with fludarabine in previously treated patients with low‐grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis JC Byrd, JB Hargis, KE Kester, DR Hospenthal, SW Knutson, LF Diehl American journal of hematology 49 (2), 135-142, 1995 | 136 | 1995 |
Donald Gray HeppnerVaxxinity, Inc.Verified email at vaxxinity.com
